The Board of Directors has appointed Ms. Lisa Juang, the company's Chief Financial Officer, as the Corporate Governance Officer, responsible for corporate governance matters. This includes the legal management of the Board of Directors, Audit Committee, Compensation Committee, and Shareholders' Meeting; assisting directors with their appointments and ongoing education; providing directors with necessary information to perform their duties; and helping directors comply with laws and regulations.

Ms. Lisa Juang has extensive experience in finance, accounting, and corporate governance. She has assisted multiple Taiwanese companies in going public and is an expert in the financial and accounting field within the biotech industry. Ms. Juang holds a degree in Accounting from Soochow University and a Master's degree in Accounting from Chinese Culture University. After joining Taiwan Bio Therapeutics, she aligned the company's strategy for expanding into international markets, assisted in establishing the U.S. subsidiary, built the financial and internal control governance systems for the multinational company, and led the company's public offering plan. Prior to joining Taiwan Bio Therapeutics, she served as the head of finance, accounting, and corporate governance in several listed companies, specializing in financial accounting, corporate governance, and internal control system development, laying a solid foundation for Taiwan Bio Therapeutics' internationalization and sustainable development.